Impact of an Immunoglobulin G-Specific Enzyme-Linked Immunosorbent Assay on the Management of Heparin-Induced Thrombocytopenia
Author:
Affiliation:
1. Department of Pharmacy; Brigham and Women's Hospital; Boston Massachusetts
2. Department of Clinical Laboratories; Brigham and Women's Hospital; Boston Massachusetts
3. Department of Hematology; Brigham and Women's Hospital; Boston Massachusetts
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1322/fullpdf
Reference19 articles.
1. New approaches to the diagnosis of heparin-induced thrombocytopenia;Warkentin;Chest,2005
2. Heparin-induced thrombocytopenia: a ten-year retrospective;Warkentin;Annu Rev Med,1999
3. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery;Selleng;Am Heart J,2010
4. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes;Greinacher;J Thromb Haemost,2007
5. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?;Warkentin;J Lab Clin Med,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Thrombotic disorders and laboratory assessment;Rodak's Hematology;2020
2. Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program;Journal of Thrombosis and Thrombolysis;2016-08-08
3. Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced Thrombocytopenia;Clinical and Applied Thrombosis/Hemostasis;2016-07-10
4. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia;American Journal of Hematology;2015-07-21
5. Medication Use Evaluation: Pharmacist Rubric for Performance Improvement;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2014-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3